Are there curative options to peritoneal carcinomatosis?
Sugarbaker
Paul H
PH
D002277:Carcinoma / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007813:Laparotomy / Q000009:adverse effects / Q000379:methods; D008297:Male; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D010534:Peritoneal Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D010537:Peritoneum / Q000187:drug effects / Q000601:surgery; D011379:Prognosis; D012042:Registries; D018570:Risk Assessment; D016896:Treatment Outcome